RESUMEN
In a large, pragmatic clinical trial, we calculated the costs of achieving four successful patient-centered outcomes using a tailored patient activation DXA result letter accompanied by a bone health brochure. The cost to achieve one successful outcome (e.g., a 0.5 standard deviation improvement in care satisfaction) ranged from $127.41 to $222.75. INTRODUCTION: Pragmatic randomized controlled trials (RCTs) should focus on patient-centered outcomes and report the costs for achieving those outcomes. We calculated per person incremental intervention costs, the number-needed-to-treat (NNT), and incremental per patient costs (cost per NNT) for four patient-centered outcomes in a direct-to-patient bone healthcare intervention. METHODS: The Patient Activation after DXA Result Notification (PAADRN) pragmatic RCT enrolled 7749 patients presenting for DXA at three health centers between February 2012 and August 2014. Interviews occurred at baseline and 52 weeks post-DXA. Intervention subjects received an individually tailored DXA result letter accompanied by an educational bone health brochure 4 weeks post-DXA, while the usual care subjects did not. Outcomes focused on patients (a) correctly identifying their results, (b) contacting their providers, (c) discussing their results with their providers, and (d) satisfaction with their bone healthcare. NNTs were determined using intention-to-treat linear probability models, per person incremental intervention costs were calculated, and costs per NNT were computed. RESULTS: Mean age was 66.6 years old, 83.8% were women, and 75.3% were non-Hispanic whites. The incremental per patient cost (costs per NNT) to increase the ability of a patient to (a) correctly identify their DXA result was $171.07; (b) contact their provider about their DXA result was $222.75; (c) discuss their DXA result with their provider was $193.55; and (d) achieve a 0.5 SD improvement in satisfaction with their bone healthcare was $127.41. CONCLUSION: An individually tailored DXA result letter accompanied by an educational brochure can improve four patient-centered outcomes at a modest cost. TRIAL REGISTRATION: clinicaltrials.gov identifier NCT01507662.
Asunto(s)
Costos de la Atención en Salud/estadística & datos numéricos , Conocimientos, Actitudes y Práctica en Salud , Osteoporosis/diagnóstico , Absorciometría de Fotón , Anciano , Alabama , Comunicación , Correspondencia como Asunto , Femenino , Georgia , Humanos , Masculino , Persona de Mediana Edad , Osteoporosis/psicología , Folletos , Educación del Paciente como Asunto/economía , Educación del Paciente como Asunto/métodos , Evaluación del Resultado de la Atención al Paciente , Satisfacción del Paciente , Relaciones Médico-PacienteRESUMEN
Prolactin secretion from the anterior pituitary is mediated via dopaminergic pathways. Any process that alters dopamine production or transport in the central nervous system may lead to hyperprolactinemia. Most cases of hyperprolactinemia are due to prolactin secreting pituitary tumors or to medications which alter dopamine production. Prolactinomas cause amenorrhea, galactorrhea and infertility in women and impotence and neurological deficits in men. Dopamine receptor agonists are the mainstay of therapy for hyperprolactinemia as they rapidly lower serum prolactin and cause tumor shrinkage. In this paper we review the regulation of prolactin secretion, the clinical features and causes of hyperprolactinemia, and the use of dopamine agonists.
Asunto(s)
Agonistas de Dopamina/farmacología , Hipófisis/efectos de los fármacos , Hipófisis/metabolismo , Prolactina/antagonistas & inhibidores , Prolactina/metabolismo , Humanos , Hiperprolactinemia/complicaciones , Hiperprolactinemia/tratamiento farmacológico , Hiperprolactinemia/etiología , Hiperprolactinemia/fisiopatología , Hipotiroidismo/complicaciones , Hipotiroidismo/fisiopatología , Hipófisis/fisiopatología , Prolactinoma/complicaciones , Prolactinoma/fisiopatología , Estrés Fisiológico/complicaciones , Estrés Fisiológico/fisiopatologíaRESUMEN
Skeletal mass declines in all populations with age, and the literature suggests that changes in oral bone may be linked to the status of the post-cranial (systemic) skeleton. However, there is a lack of information defining the relationship between alveolar process bone and the post-cranial skeleton in healthy individuals. The purpose of this study was to determine: (1) if the bone densities of the maxillary and mandibular alveolar processes are related to the bone density of the spine, hip, or radius in healthy women; and (2) if the alveolar process densities decline with age. Forty-one dentate Caucasian women aged 20 to 78 years underwent assessment of post-cranial (systemic) and alveolar process bone. D-speed vertical bitewing and periapical radiographs incorporating aluminum stepwedges, controlled exposure and processing conditions, and a density correction algorithm were used to make alveolar process density assessments with regions of interest (ROIs) apical to crestal bone and intrabony defects. Anteroposterior lumbar (L1 to L4) and lateral lumbar (L2 to L4) spine, total hip (and subregions), and radius bone densities were determined by dual-energy x-ray absorptiometry (DEXA). Correlation analysis revealed significant relationships between maxillary alveolar process bone density and the density of the mandibular alveolar process (r = 0.57, p < or = 0.001), anteroposterior lumbar spine (r = 0.53, p < or = 0.001), lateral lumbar spine (r = 0.52, p < or = 0.001), total hip (r = 0.39, p = 0.01), total radius (r = 0.39, p = 0.01), and age (r = -0.38, p = 0.01). A two-tailed t test comparison revealed significantly greater maxillary alveolar process bone density in women younger than 50 years of age than in those 50 and older (p < or = 0.01). We conclude that the density of maxillary alveolar process bone is significantly related to the density of the mandibular alveolar process, lumbar spine, hip, and radius in healthy women and that maxillary alveolar process bone density declines with age.
Asunto(s)
Proceso Alveolar/anatomía & histología , Densidad Ósea , Huesos/anatomía & histología , Absorciometría de Fotón , Adulto , Factores de Edad , Anciano , Algoritmos , Proceso Alveolar/diagnóstico por imagen , Femenino , Articulación de la Cadera/anatomía & histología , Humanos , Vértebras Lumbares/anatomía & histología , Mandíbula/anatomía & histología , Mandíbula/diagnóstico por imagen , Maxilar/anatomía & histología , Maxilar/diagnóstico por imagen , Persona de Mediana Edad , Intensificación de Imagen Radiográfica , Radiografía de Mordida Lateral , Radio (Anatomía)/anatomía & histología , Estadística como AsuntoAsunto(s)
Alucinógenos , Dietilamida del Ácido Lisérgico , Mesenterio , Antagonistas de la Serotonina , Agonistas de Receptores de Serotonina , Trastornos Relacionados con Sustancias/complicaciones , Adulto , Enfermedad Crónica , Humanos , Masculino , Mesenterio/patología , Enfermedades Peritoneales/complicacionesRESUMEN
Systemic lupus erythematosus (SLE), a chronic autoimmune illness, is influenced by hormones. High prolactin concentrations were associated with early death from autoimmune renal disease in NZB/NZW mice, an animal model of severe SLE. NZB/NZW mice that delivered and nursed pups and those that underwent pseudopregnancy had changes in serum IgG and autoantibodies. NZB/NZW mice treated with the prolactin-suppressing drug bromocriptine had prolonged lives. Elevated serum prolactin concentrations are reported in SLE patients of both sexes. We found four women with long-standing hyper-prolactinemia who developed SLE. A survey of premenopausal women whose sera were submitted for autoantibody testing showed that 20% with anti-ds-DNA antibodies also had high prolactin levels. Many hyperprolactinemic patients whose sera were referred to an endocrinology laboratory had positive FANA tests (women 33%, men 53%) but did not have SLE. Disease activity was suppressed in six of seven SLE patients treated with bromocriptine. All had elevated disease activity and five became unexpectedly hyperprolactinemic after treatment stopped. Manipulating serum prolactin affords a means of treating clinical SLE activity.
Asunto(s)
Lupus Eritematoso Sistémico/fisiopatología , Prolactina/fisiología , Bromocriptina/uso terapéutico , Antagonistas de Hormonas/uso terapéutico , Humanos , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/tratamiento farmacológico , Prolactina/sangreAsunto(s)
Enfermedades del Sistema Endocrino/terapia , Enfermedades Óseas/tratamiento farmacológico , Diabetes Mellitus/diagnóstico , Diabetes Mellitus/tratamiento farmacológico , Femenino , Hormona de Crecimiento Humana/uso terapéutico , Humanos , Hiperlipidemias/tratamiento farmacológico , Resistencia a la Insulina , Síndrome del Ovario Poliquístico/tratamiento farmacológicoRESUMEN
BACKGROUND AND OBJECTIVES: Satisfaction is known to impact work performance, learning, recruitment, and retention. This study identifies the factors associated with primary care residents' satisfaction with their training. METHODS: We used a cross-sectional survey based on the Price-Mueller model of job satisfaction. The model included 14 job characteristics, four personal characteristics, and four demographic factors. Data were collected in February and March 1996 from residents in three primary care training programs (family practice, pediatrics, and internal medicine) at a large academic medical center. The same standardized, self-administered questionnaires were used in all three departments. RESULTS: Seventy-five percent (n = 119) of the residents returned questionnaires. Five job characteristics were positively associated with resident satisfaction: continuity of care, autonomy, collegiality, work that encourages professional growth, and work group loyalty. Role conflict, a sixth job characteristic, was negatively associated with satisfaction. The personal characteristic of having an optimistic outlook on life was also positively associated with satisfaction. The model explained 66% of the variation in self-reported satisfaction. CONCLUSIONS: The satisfaction of the residents was significantly associated with six job characteristics and one personal factor. Interventions based on these job characteristics may increase resident satisfaction and may lead to better patient outcomes, better work performance, greater patient satisfaction, and more success in recruiting top students into a residency.
Asunto(s)
Educación Médica/normas , Educación/normas , Internado y Residencia , Satisfacción Personal , Médicos de Familia/educación , Educación/tendencias , Educación Médica/tendencias , Femenino , Humanos , Internado y Residencia/métodos , Internado y Residencia/normas , Internado y Residencia/tendencias , Iowa , Masculino , Estudios Retrospectivos , Encuestas y CuestionariosRESUMEN
Prolactinomas are benign, functioning pituitary tumours that cause reproductive dysfunction in men and women. PRL-secreting microadenomas have a benign clinical course and may even disappear without treatment. Absolute indications for treatment of hyperprolactinaemia include the need to restore fertility and the presence of a macroadenoma. A dopamine agonist is the treatment of choice regardless of tumour size and will normalize PRL and restore menses in the majority of cases. Hypogonadism induced by hyperprolactinaemia is associated with decreased spinal bone mineral content, but it is not clear whether the bone loss is progressive. Bone mass improves after treatment of the hyperprolactinaemia but does not normalize. The safety of chronic oestrogen therapy in women with hyperprolactinaemic amenorrhoea who are not desirous of fertility remains to be elucidated by ongoing clinical trials.
Asunto(s)
Hiperprolactinemia/fisiopatología , Hiperprolactinemia/terapia , Enfermedades Óseas Metabólicas/etiología , Estrógenos/uso terapéutico , Femenino , Humanos , Hiperprolactinemia/complicaciones , Masculino , Prolactina/metabolismoRESUMEN
PURPOSE: To measure and evaluate the temporal enhancement characteristics of the normal pituitary gland and pituitary adenoma. METHODS: Thirty healthy subjects and 10 patients with sellar pituitary adenomas were studied prospectively using dynamic MR imaging with a 5- or 10-sec temporal resolution during a bolus injection of gadolinium. RESULTS: Qualitative visual analysis demonstrated a consistent sequential pattern of pituitary enhancement in which the posterior lobe enhanced earlier than the anterior lobe by approximately 35 sec. Quantitative analysis revealed that posterior lobe enhancement occurred 9.8 +/- 1.5 sec (mean +/- SEM) before the anterior lobe in healthy subjects, whereas tumor enhancement occurred significantly before the anterior lobe but only slightly before the posterior lobe in patients with adenomas. CONCLUSION: The sequential enhancement pattern of the normal pituitary gland was found to be consistent with its vascular anatomy. In contrast to previous reports, pituitary adenomas were found to enhance earlier than the anterior lobe. These results suggest that pituitary adenomas have a direct arterial blood supply, similar to that of the posterior pituitary lobe.
Asunto(s)
Adenoma/diagnóstico , Aumento de la Imagen , Imagen por Resonancia Magnética , Hipófisis/anatomía & histología , Neoplasias Hipofisarias/diagnóstico , Medios de Contraste , Gadolinio DTPA , Humanos , Compuestos Organometálicos , Ácido Pentético/análogos & derivados , Hipófisis/patología , Estudios ProspectivosRESUMEN
Common thyroid and parathyroid disorders present with reversible neurologic signs and symptoms affecting the central and peripheral nervous system, musculature, and mental function. Patients with thyrotoxicosis may have myopathy, spasticity, seizures, and multiple psychiatric symptoms. A deficiency of thyroid hormone also causes muscle weakness and may be accompanied by reversible muscle hypertrophy or movement disorders. The chronic hypercalcemia that develops secondary to hyperparathyroidism produces many psychiatric and cognitive symptoms, as well as a reversible myopathy. Calcium deficiency leads to neuromuscular irritability, paresthesias, and tetany. Psychiatric disorders are also common in this disorder.
Asunto(s)
Enfermedades de las Paratiroides/complicaciones , Enfermedades de la Tiroides/complicaciones , Diagnóstico Diferencial , Humanos , Escala del Estado Mental , Trastornos del Movimiento/etiología , Trastornos del Movimiento/fisiopatología , Espasticidad Muscular/etiología , Espasticidad Muscular/fisiopatología , Enfermedades de las Paratiroides/diagnóstico , Enfermedades de las Paratiroides/fisiopatología , Convulsiones/etiología , Convulsiones/fisiopatología , Enfermedades de la Tiroides/diagnóstico , Enfermedades de la Tiroides/fisiopatologíaRESUMEN
A 52-year-old woman developed recurrent hypercortisolism 3 yr after successful surgical treatment of Cushing's disease. At postmortem, eosinophilic pituitary tissue showing positive ACTH immunohistochemical staining was present in the frontal lobe and cerebellum but there was no tumor in the sella. In the absence of a pituitary tumor, extrasellar ACTH producing tissue could arise from seeding of the cerebrospinal fluid with tumor cells at the time of operation or from an atypical pituitary carcinoma. In this report we review the mechanisms of intracranial dissemination of pituitary tissue and ACTH-secreting pituitary carcinomas, including parasellar invasion, meningeal seeding, and cerebrospinal and hematogenous spread.
Asunto(s)
Adenoma/metabolismo , Hormona Adrenocorticotrópica/metabolismo , Neoplasias Hipofisarias/metabolismo , Adenoma/patología , Adenoma/secundario , Neoplasias Encefálicas/etiología , Síndrome de Cushing/complicaciones , Síndrome de Cushing/patología , Síndrome de Cushing/cirugía , Dexametasona , Femenino , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Metástasis de la Neoplasia , Neoplasias Hipofisarias/patología , Neoplasias Hipofisarias/secundarioRESUMEN
Potential biologic and psychosocial causative factors for the postpartum blues were tested in a prospective study of 182 women followed up from the second trimester of pregnancy until postpartum week 9. Personal and family history of depression, depressive symptoms, stressful life events, and social adjustment were all assessed during the second trimester. Levels of progesterone, prolactin, estradiol, free and total estriol, and free and total cortisol were measured on several occasions during late pregnancy and early puerperium. Obstetric and child-care stressors and the postpartum blues were assessed after delivery. Predictors of the postpartum blues were personal and family history of depression, social adjustment, stressful life events, and levels of free and total estriol. Our results support the hypothesis that the postpartum blues is within the spectrum of affective disorders.
Asunto(s)
Depresión/diagnóstico , Trastorno Depresivo/diagnóstico , Trastornos Puerperales/diagnóstico , Adulto , Lactancia Materna , Depresión/etiología , Trastorno Depresivo/etiología , Estriol/sangre , Femenino , Humanos , Acontecimientos que Cambian la Vida , Matrimonio , Embarazo , Complicaciones del Embarazo/diagnóstico , Síndrome Premenstrual/diagnóstico , Estudios Prospectivos , Escalas de Valoración Psiquiátrica , Trastornos Puerperales/etiología , Factores de Riesgo , Índice de Severidad de la Enfermedad , Ajuste SocialRESUMEN
To investigate possible effects of chronic marijuana use on reproductive and stress hormones, we assayed testosterone, luteinizing hormone, follicle stimulating hormone, prolactin, and cortisol in 93 men and 56 women with a mean (+/- S.E.) age of 23.5 +/- 0.4 years. Hormone values were compared among groups of subjects stratified according to frequency of marijuana use (frequent, moderate and infrequent; N = 27, 18, and 30, respectively) and non-using controls (N = 74). Chronic marijuana use showed no significant effect on hormone concentrations in either men or women.
Asunto(s)
Hormona Folículo Estimulante/sangre , Hidrocortisona/sangre , Hormona Luteinizante/sangre , Abuso de Marihuana/sangre , Prolactina/sangre , Testosterona/sangre , Adolescente , Adulto , Nivel de Alerta/efectos de los fármacos , Nivel de Alerta/fisiología , Femenino , Humanos , Masculino , Psicotrópicos , Trastornos Relacionados con Sustancias/sangreRESUMEN
Demographic, psychiatric, social, cognitive, and life stress variables were used to determine the etiology of depression in childbearing (CB; n = 182) and nonchildbearing (NCB; n = 179) women. Hormonal variables in postpartum depression were also evaluated. In the CB group predictors of depression diagnosis were previous depression, depression during pregnancy, and a Vulnerability (V) x Life Stress (LS) interaction; predictors of depressive symptomatology were previous depression, depressive symptoms during pregnancy, life events, and V x LS. Only estradiol was associated with postpartum depression diagnosis. In the NCB group V X LS was the only predictor of depression diagnosis; depressive symptoms during pregnancy and life events were predictors of depressive symptomatology. Previous findings about depression vulnerability were replicated. The significant V x LS interactions support the vulnerability-stress model of postpartum depression.
Asunto(s)
Trastorno Depresivo/diagnóstico , Trastornos Puerperales/diagnóstico , Adulto , Trastorno Depresivo/etiología , Estradiol/sangre , Femenino , Humanos , Acontecimientos que Cambian la Vida , Embarazo , Estudios Prospectivos , Trastornos Puerperales/etiología , Estrés PsicológicoRESUMEN
Factors, both personal and job-related in nature, that influence career choice among radiology residents are identified. Twenty-six third and fourth year radiology residents at two separate locations, and 17 age-matched and sex-matched internal medicine residents completed a 30-minutes interview and rated themselves on a series of job-related competencies. Data were collected on five groups of variables: demographic data, residency-related variables, factors that influence career choice, self-descriptions, and personal competencies. The results indicate that residents who choose academic careers and those who plan to have private practice careers differ substantially in their reasons for career choice. An academic career is chosen because of its atmosphere, emphasis on research and specialized techniques, and opportunity for teaching. In contrast, private practice careers are selected because of the autonomy they allow, the accompanying lifestyle, and financial reimbursement.
Asunto(s)
Selección de Profesión , Práctica Profesional , Radiología , Investigación , Humanos , Internado y Residencia , Encuestas y Cuestionarios , Estados UnidosRESUMEN
3-Aminobenzamide, a general inhibitor of poly(ADP-ribose)polymerase, potentiated the triamcinolone acetonide-mediated growth inhibition and lysis of the glucocorticoid-sensitive CEM-C7 human leukemic cell line. This potentiation was dose-dependent with maximal response being detected at 3 mM 3-aminobenzamide, and was completely blocked by the glucocorticoid receptor antagonist RU 38486. Scatchard analysis of whole cell specific [3H]triamcinolone acetonide binding data did not reveal any effect of 3-aminobenzamide on either the number of intracellular receptor binding sites or their affinity for the agonist. Treatment of the ICR-27 cell line, which is a glucocorticoid resistant mutant isolated from CEM-C7, with 3-aminobenzamide did not restore triamcinolone acetonide sensitivity. Similarly, 3-aminobenzamide treatment of several other lymphoid cell lines (human HL60 and IM-9 and murine L1210 cells) which contain functional receptors but are not normally lysed by glucocorticoid agonists, failed to induce sensitivity to triamcinolone acetonide. Since treatment of sensitive lymphoid cells with glucocorticoid agonists results in DNA fragmentation prior to cell death, these data suggest that 3-aminobenzamide potentiates the cytolytic response of sensitive cells to glucocorticoid agonists by inhibiting DNA excision repair mechanisms.
Asunto(s)
Adenosina Difosfato/metabolismo , Benzamidas/farmacología , Leucemia Linfoide/patología , Inhibidores de Poli(ADP-Ribosa) Polimerasas , Triamcinolona Acetonida/farmacología , Sitios de Unión/efectos de los fármacos , División Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Humanos , Leucemia Linfoide/metabolismo , Linfocitos/efectos de los fármacos , Linfocitos/metabolismo , Linfocitos/patología , Triamcinolona Acetonida/metabolismo , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/metabolismo , Células Tumorales Cultivadas/patologíaRESUMEN
To evaluate the effect of glucocorticoids on corticosteroid binding globulin (CBG), we measured the binding capacity and binding affinity of cortisol for CBG in normal subjects, patients receiving glucocorticoids and patients with Cushing's syndrome. Normal subjects had a mean binding capacity of 3.8 (+/- SD 0.7) X 10(-7) mol/l and mean binding affinity of 1.96 +/- 0.48 X 10(-8) M. Patients with Cushing's syndrome had a 40% decrease in binding capacity (2.3 +/- 0.4 X 10(-7) mol/l) compared to control subjects and significantly lower mean binding capacity than patients receiving pharmacological (2.9 +/- 0.6 X 10(-7) mol/l) and physiological doses of glucocorticoids (3.4 +/- 0.6 X 10(-7) mol/l) (P = 0.05 one-way analysis of variance). Patients with endogenous cortisol excess also had significantly lower mean binding affinity (1.54 +/- 0.37 X 10(-8) M) than normal subjects and glucocorticoid treated subjects. These changes suggest that both endogenous and exogenous glucocorticoids can modulate circulating levels of CBG and may have important implications for patients receiving steroid therapy.
Asunto(s)
Glucocorticoides/farmacología , Transcortina/metabolismo , Insuficiencia Suprarrenal/sangre , Insuficiencia Suprarrenal/tratamiento farmacológico , Adulto , Anciano , Síndrome de Cushing/sangre , Femenino , Glucocorticoides/uso terapéutico , Humanos , Hidrocortisona/sangre , Masculino , Persona de Mediana EdadRESUMEN
Meningiomas have been shown to have steroid-binding proteins. In vitro, estradiol, progesterone, and the antiestrogen tamoxifen stimulate tumor growth. However, incubation of tumor cells with an antiprogesterone agent results in tumor inhibition. In this investigation, a human meningioma was implanted subcutaneously in athymic nude mice. Two treatment groups were established, one receiving the antiprogesterone agent RU-38486 (10 mg/kg/day in suspension) and the other receiving only vehicle. After 3 months, the tumor growth index (defined as the tumor volume at 3 months divided by the initial tumor volume) was 0.25 +/- 0.46 (mean +/- standard deviation) in the group receiving antiprogesterone and was 1.54 +/- 0.58 in the control group (p = 0.041). Further investigation of the effect of antiprogestational agents on the growth and hormone-binding proteins of other meningiomas will better define the mechanism of their effects.